Emily Field analyst BARCLAYS

Currently out of the existing stock ratings of Emily Field, 43 are a BUY (53.75%), 27 are a HOLD (33.75%), 10 are a SELL (12.5%).

Emily Field

Work Performance Price Targets & Ratings Chart

Analyst Emily Field, currently employed at BARCLAYS, carries an average stock price target met ratio of 53.03% that have a potential upside of 24.84% achieved within 278 days.

Emily Field’s has documented 138 price targets and ratings displayed on 12 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical sectors.

Most recent stock forecast was given on NVO, Novo Nordisk A/S at 30-Jul-2025.

Wall Street Analyst Emily Field

Analyst best performing recommendations are on GLPG (GALAPAGOS NV ADR).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 3/2/2021. The price target of $82.77 was fulfilled within 1 day with a profit of $1.59 (1.88%) receiving and performance score of 18.85.

Average potential price target upside

ARGX argenx NV ADR AZN AstraZeneca PLC ADR GLPG Galapagos NV ADR GMAB Genmab AS GSK GlaxoSmithKline PLC ADR NVO Novo Nordisk A/S NVS Novartis AG ADR UCBJY UCB SA ADR SNY Sanofi ADR GRFS Grifols SA ADR HL Hecla Mining Company IP International Paper

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Nov-2017

$1150

$165.61 (16.82%)

$1150

Buy Since 03-Jul-2025

$1250

$265.61 (26.98%)

$1230

12 days ago
(31-Aug-2026)

2/4 (50%)

$218.34 (21.16%)

192

Hold Since 06-Nov-2023

$1400

$415.61 (42.22%)

$910

17 days ago
(26-Aug-2026)

7/8 (87.5%)

$352.9 (33.70%)

218

Buy Since 14-Sep-2018

$1415

$430.61 (43.74%)

$1260

17 days ago
(26-Aug-2026)

21/26 (80.77%)

$367.9 (35.14%)

204

Buy Since 25-Aug-2025

$1100

$115.61 (11.74%)

$1025

25 days ago
(18-Aug-2026)

6/7 (85.71%)

$107.01 (10.78%)

74

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Emily Field?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?